ஐ.எஸ்.எஸ்.என்: 2332-0737
Jeffrey Johnson
In the battle against cancer, researchers have increasingly turned their focus towards targeting tumour vasculature as a promising therapeutic strategy. This approach, rooted in the understanding of angiogenesis, holds significant potential for disrupting the blood supply to tumours and impeding their growth and progression. By unravelling the intricate mechanisms underlying angiogenesis in cancer, scientists are paving the way for innovative treatments aimed at delivering therapeutic benefits to patients.